TY  - JOUR

T1  - Targeting <scp><i>HER2</i></scp><i>/</i><scp><i>HER3</i></scp> co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy

JO  - Cancer Reports

UR  - https://doi.org/10.1002/cnr2.1954

PY  - 2024/03/05

AU  - Blas PE

AU  - Rodriguez ESR

AU  - Williams HL

AU  - Levin MK

AU  - Bell JSK

AU  - Pierobon M

AU  - Barrett AS

AU  - Petricoin EF

AU  - O'Shaughnessy JA

ED  - 

DO  - DOI: 10.1002/cnr2.1954

PB  - Wiley

VL  - 7

IS  - 3

Y2  - 2026/03/17

ER  -